main content start
About Us
ADA Newsroom
Get the latest news from ADA, including press releases and research announcements.
Press Releases
If you are looking for ADA press releases issued prior to 2019, please email press@diabetes.org.
Recent Press release
Press release
One in Four Patients with Difficult-to-Control Type 2 Diabetes Experience High Levels of Cortisol
Largest-Study-of-its-Kind Uncovers Potential Underlying
Press release
Common Type 2 Diabetes Drug Shown to Safely Reduce the Progression of Kidney Disease in Adolescents with Type 1 Diabetes
SGLT2i Shown as Potential Solution to Help Manage Renal
Press release
Semaglutide Reduced Risk for Major Kidney Disease Events by 24% for Patients with Type 2 Diabetes and Kidney Disease
American Diabetes Association Symposium Showcases New
Official Statement
Recent Press release
Press release
One in Four Patients with Difficult-to-Control Type 2 Diabetes Experience High Levels of Cortisol
Largest-Study-of-its-Kind Uncovers Potential Underlying
Press release
Common Type 2 Diabetes Drug Shown to Safely Reduce the Progression of Kidney Disease in Adolescents with Type 1 Diabetes
SGLT2i Shown as Potential Solution to Help Manage Renal
Press release
Semaglutide Reduced Risk for Major Kidney Disease Events by 24% for Patients with Type 2 Diabetes and Kidney Disease
American Diabetes Association Symposium Showcases New
Press release
Late Breaking Weight Loss Innovations: New Drug Therapies Shown to Offer Positive Outcomes for Obesity and Type 2 Diabetes Management
Novel Weight Loss Drug, Survodutide, Shows Significant Weight Loss of Nearly 19% At 46 Weeks Oral Semaglutide Demonstrates Weight Loss Up…
Press release
American Diabetes Association Releases Updates to the 2023 Standards of Care in Diabetes on the Use of Teplizumab in Delaying the Onset of Type 1 Diabetes
Today, the American Diabetes Association ® (ADA) published updates to the Standards of Care in Diabetes—2023 (Standards of Care) on the…
Press release
American Diabetes Association Releases a Guideline Update in NAFLD (Non-Alcoholic Fatty Liver Disease) and Diabetes
New guidelines include recommendations for the detection and management of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic
Meet Our Experts
The American Diabetes Association is proud to partner with leading experts in the field of diabetes—each one directed to advancing the treatment and prevention of this disease.
Charles D. Henderson
Chief Executive Officer
Robert Gabbay, MD, PhD
Chief Scientific and Medical Officer
Lisa Murdock
Chief Advocacy Officer
Nuha El Sayed, MD, MMSc
Senior Vice President, Health Care Improvement
Marlon Pragnell, PhD
Vice President, Research & Science
Crystal Woodward, MPS
Managing Director, Legal Advocacy/Safe at School
Your support helps drive lifesaving research, advocacy, and programs to help improve the lives of people living with diabetes.
Donate Now and DOUBLE your impact.